Effusions

  • Peter Spieler
  • Matthias Rössle
Part of the Essentials of Diagnostic Pathology book series (ESSENTPATH)

Abstract

Benign and malignant disorders occurring in varying serous body cavities are described extensively with special focus on lymphoid lesions, malignant mesothelioma, secondary tumors, and primary effusion lymphoma. Particular lesions which may be encountered in aspirates and washings from Douglas pouch and peritoneal cavity respectively, are discussed in a separate section. A fourth section exhibits cytopathology of synovial fluid.

Cytodiagnostic algorithms of benign and malignant lesions seen in effusions, aspirates, and washings and their respective differential diagnoses are additionally presented in synoptic setups.

Keywords

Mesothelial Cell Malignant Mesothelioma Granulosa Cell Tumor Primary Effusion Lymphoma Psammoma Body 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

Further Reading (Sect. 3.1)

  1. 1.
    Afify AM, Al-Khafaji BM, Paulino AF, Davila RM. Diagnostic use of muscle markers in the cytologic evaluation of serous fluids. Appl Immunohistochem Mol Morphol 2002;10:178-82.PubMedCrossRefGoogle Scholar
  2. 2.
    Beeson PB, Bass DA. The Eosinophil. Philadephia, WB Saunders, 1977.Google Scholar
  3. 3.
    Boddington MM,Spriggs AI, Morton Ja, Mowat AG. Cytodiagnosis of rheumatoid pleural effusion. J Clin Pathol 1971;24:95-106.PubMedCrossRefGoogle Scholar
  4. 4.
    Chang CJ, Cheng JH, Lin MS, et al. J Formos Med Assoc 2007;106:156-160.PubMedCrossRefGoogle Scholar
  5. 5.
    Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006;34:335-347.PubMedCrossRefGoogle Scholar
  6. 6.
    Domfeh AB, Nodit L, Gradowski JF, Bastacky S. Mycobacterium kansasii infection diagnosed by pleural fluid cytology. a case report. Acta Cytol 2007;51:627-630.PubMedCrossRefGoogle Scholar
  7. 7.
    Ellman Ph, Cudkowics L, Elwood JS. Widespread serous membrane involvement by rheumatoid nodules. J Clin Path 1954;7:239-244.PubMedCrossRefGoogle Scholar
  8. 8.
    Galed-Placed I. Immunoglobulin Crystal-Storing histiocytosis in a Pleural Effusion from a woman with Iga kappa Multiple Myeloma. A case report. Acta Cytol 2006;50:539-541.PubMedCrossRefGoogle Scholar
  9. 9.
    Gill SA, Meier P A, Kendall BS. Use of desmin immunohistochemistry to distinguish between mesothelial cells and carcinoma in serous fluid cell block preparations. Acta Cytol 2000;44:976-80.PubMedCrossRefGoogle Scholar
  10. 10.
    Guzman J, Bross KJ, Wurtemberger G, et al. Tuberculous pleural effusions: Lymphocyte phenotypes in comparison with other lymphocyte-rich effusions. Diagn Cytopathol 1989;5:139.PubMedCrossRefGoogle Scholar
  11. 11.
    Kalomenidis I, Light RW. Pathogenesis of the eosinophilic pleural effusions. Curr Opin Pulm Med 2004;10:289-293.PubMedCrossRefGoogle Scholar
  12. 12.
    Keagle M, Marcks KA, Kaiser JS. Cytologic manifestation of rheumatoid arthritis in pleural effusion. Acta Cytol 1981;25:33-36.PubMedGoogle Scholar
  13. 13.
    King J, Thatcher N, Pickering C, Hasleton P. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports. Histopathology 2006;49:561-568.PubMedCrossRefGoogle Scholar
  14. 14.
    Martin AW, Carstens PHB, Yam LT. Crystalline deposits in ascites in a case of cryoglobulinemia. Acta Cytol 1987;31:631-636.PubMedGoogle Scholar
  15. 15.
    Matthai SM, Kini U. Diagnostic value of eosinophils in pleural effusion: a prospective study of 26 cases. Diagn Cytopathol 2003;28:96-99.PubMedCrossRefGoogle Scholar
  16. 16.
    Nagaoka S, Maruyama R, Koike M, et al. Cytology of Langerhans cellhistiocytosisineffusions:acasereport.ActaCytol1996;40:563-566.Google Scholar
  17. 17.
    Naylor B. Pleural, Peritoneal and Pericardial fluids. In: Bibbo M. (ed). Comprehensive Cytopathology. W.B. Saunders Company, Philadelphia, 1991,p.569.Google Scholar
  18. 18.
    Nosanchuk JS, Naylor B. A unique cytologic picture in pleural fluid from patients with rheumatoid arthritis. Amer J Clin Pathol 1968;50:330-335.Google Scholar
  19. 19.
    Olson PR, Silverman JF, Powers CN. Pleural fluid cytology of Hodgkin’s disease: Cytomorphologic features and the value of immunohistochemical studies. Diagn Cytopathol 2000,22:21-24.PubMedCrossRefGoogle Scholar
  20. 20.
    Pappas CA, Rheinlander HF, Stadecker MJ. Pleural effusion as a complication of solitary eosinophilic granuloma of the rib. Hum Pathol 1980;11:675-677.PubMedCrossRefGoogle Scholar
  21. 21.
    Spieler P. Beurteilung und Bedeutung cholesterinhaltiger Punktionsflüssigkeiten aus dem Abdomen. Schweiz med Wschr 1976;106:1510-1513.PubMedGoogle Scholar
  22. 22.
    Spieler P. The cytologic diagnosis of tuberculosis in pleural effusion. Acta Cytol 1979;23:374-379.PubMedGoogle Scholar
  23. 23.
    Spieler P, Hell M. Serous rheumatoid disease following chronic polyarthritis. Five cases with special regard to cytopathology. Schweiz med Wschr 1984;114:1110-1117.PubMedGoogle Scholar
  24. 24.
    Spieler P, Kradolfer D, Schmid U. Immunocytochemical characterization of lymphocytes in benign and malignant lymphocyterich serous effusions. Virchows Arch Pathol Anat 1986;409:211-221.CrossRefGoogle Scholar
  25. 25.
    Spriggs AI. Pleural eosinophilia due to pneumothorax. Acta Cytol 1979;23:425.PubMedGoogle Scholar
  26. 26.
    Spriggs AI, Boddington MM. Absence of mesothelial cells from tuberculous pleural effusions. Thorax 1960;15:169-171.PubMedCrossRefGoogle Scholar
  27. 27.
    Tynski Z, Eisenberg R. Cytologic findings of lymphangioleiomyomatosis in pleural effusions. Acta Cytol 2007;51:578-580.PubMedCrossRefGoogle Scholar
  28. 28.
    Veress JF, Koss LG, Schreiber K. Eosinophilic pleural effusions. Acta Cytol 1979;23:40-44.PubMedGoogle Scholar
  29. 29.
    Ward R. Pleural effusion and rheumatoid disease. Lancet 1961;2:1336-1338.PubMedCrossRefGoogle Scholar
  30. 30.
    Winkler CF, Yam LT. Pleural effusion in histiocytosis X. Arch Intern Med 1980;140:988.PubMedCrossRefGoogle Scholar
  31. 31.
    Zaharopoulos P, Wen JW, Wong D. Membranous lamellar cytoplasmic inclusions in histiocytes and mesothelial cells of serous fluids. Their relationship to phagocytosis of red blood cells. Acta Cytol 1998;42:607-613.PubMedCrossRefGoogle Scholar

Further Reading (Sect. 3.2)

  1. 1.
    Abraham MG, Levin KA, Balasubramanian M, et al. Diagnosis of T-cell lymphoma in body fluids. Cytologic features and unusual flow cytometric findings. Anal Quant Cytol Histol 2007;29:333-338.PubMedGoogle Scholar
  2. 2.
    Afify AM, Al-Khafaji BM, Paulino AF, Davila RM. Diagnostic use of muscle markers in the cytologic evaluation of serous fluids. Appl Immunohistochem Mol Morphol 2002;10:178-82.PubMedCrossRefGoogle Scholar
  3. 3.
    Aoki Y, Yarchoan R, Braun J, et al. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions. Blood 2000;96:1599-1601.PubMedGoogle Scholar
  4. 4.
    Bailey ME, Brown RW, Mody DR, et al. Ber-Ep4 for differentiating adenocarcinoma from reactive and neoplastic mesothelial cells in serous effusions. Comparison with carcinoembryonic antigen, B72.3 and Leu-M1. Acta Cytol 1996;40:1212-1216.PubMedCrossRefGoogle Scholar
  5. 5.
    Bangerter M, Hildebrand A, Griesshammer M. Combined cytomorphologic and immunophenotypic analysis in the diagnostic workup of lymphomatous effusions. Acta Cytol 2001;45:307-312.PubMedCrossRefGoogle Scholar
  6. 6.
    Battifora H, McCaughey WTE. Atlas of tumor pathology, Tumors of the serosal membranes. 3rd series,fascicle 15, Juan Rosai (ed.) Armed Forces Institute of pathology, Washington D.C., 1995 pp. 17-23 / 31.Google Scholar
  7. 7.
    Bentz JS, Rowe LR, Anderson SR, et al. Rapid detection of the t(11;14) translocation in mantle cell lymphoma by interphase fluorescence in situ hybridization on archival cytopathologic material. Cancer 2004;102:124-131.PubMedCrossRefGoogle Scholar
  8. 8.
    Brimo F, Michel RP, Khetani K, Auger M. Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 2007;111:224-233.PubMedCrossRefGoogle Scholar
  9. 9.
    Cagle PT, Brown RW, Lebovitz RM. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens. Hum Pathol 1994;25:443-448.PubMedCrossRefGoogle Scholar
  10. 10.
    Carbone A, Gloghini A. HHV-8-associated lymphoma: state-ofthe-art review. Acta Haematol 2007;117:129-131.PubMedCrossRefGoogle Scholar
  11. 11.
    Carbone A, Gloghini A. PEL and HHV8-unrelated effusion lymphomas. Classification and diagnosis. Cancer (Cancer Cytopathol) 2008;114:225-227.Google Scholar
  12. 12.
    Cesarman E, Chang Y, Moore PS, et al. Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavitybased lymphomas. N Engl J Med 1995;332:1186-1191.PubMedCrossRefGoogle Scholar
  13. 13.
    Chan JK, Suster S, Wenig BM, et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997;21:226-234.PubMedCrossRefGoogle Scholar
  14. 14.
    Chang H, Sun C-F. Detection of B-cell lymphoma involvement in T cell-rich serous fluid by immunoglobulin Gene rearrangement. A report of 2 cases. Acta Cytol 2008;52:231-234.PubMedCrossRefGoogle Scholar
  15. 15.
    Churg A, , Cagle PT, , Roggli VL. AFIP Atlas of Tumor Pathology, fourth series, fasc 3. AFIP, Tumors of the serosal membranes. ed. Silverberg SG. American Registry of Pathology, Washington DC, 2006.Google Scholar
  16. 16.
    Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood 2008;111:3941-3967.PubMedCrossRefGoogle Scholar
  17. 17.
    Czader M, Ali SZ. Flow Cytometry as an adjunct to cytomorphologic analysis of serous effusions. Diagn Cytopathol 2003;29:74-78.PubMedCrossRefGoogle Scholar
  18. 18.
    Das DK. Serous effusions in malignant lymphomas: a review. Diagn Cytopathol 2006;34:335-347.PubMedCrossRefGoogle Scholar
  19. 19.
    Davidson B, Nielsen S, Christensen J, et al. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol. 2001;25:1405-1412.PubMedCrossRefGoogle Scholar
  20. 20.
    Daya D, Mc Caughey WT. Well-differentiated papillary mesothelioma of the peritoneum. A clinicopathologic study of 22 cases. Cancer 1990;65:292-296.PubMedCrossRefGoogle Scholar
  21. 21.
    De Angelis M, Buley ID, Heryet A, Gray W. Immunocytochemical staining of serous effusions with the monoclonal antibody Ber-Ep4. Cytopathology 1992;3:111-117.PubMedCrossRefGoogle Scholar
  22. 22.
    Dejmek A. CK 5/6 in effusions. No difference between mesothelioma and pulmonary and nonpulmonary adenocarcinoma. Acta Cytol 2008;52:579-583.PubMedCrossRefGoogle Scholar
  23. 23.
    Drexler HG, Meyer C, Gaidano G, Carbone A. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 1999;13:634-640.PubMedCrossRefGoogle Scholar
  24. 24.
    Esteban JM, Sheibani K. DNA ploidy analysis of pleural mesotheliomas: its usefulness for their distinction from lung adenocarcinomas. Modern pathol 1992;5:626-630.Google Scholar
  25. 25.
    Friedman MT, Gentile P, Tarectecan A, Fuchs A. Malignant mesothelioma: Immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions. Arch Pathol Lab Med 1996;120:959-966.PubMedGoogle Scholar
  26. 26.
    Gaidano G, Gloghini A, Gattei V, et al. Association of Kaposi’s sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138/syndecan-1 antigen. Blood 1997;90:4894-4900.PubMedGoogle Scholar
  27. 27.
    Giordano G, Gnetti L, Milione M, et al. Serous psammocarcinoma of the ovary: a case report and review of the literature. Gynecol Oncol 2005;96:259-262.PubMedCrossRefGoogle Scholar
  28. 28.
    Gonzalez-Lois C, Ballestin C, Sotelo MT, et al. Combined use of novel epithelial (MOC-31) and mesothelial (HBME-1) immunohistochemical markers for optimal first line diagnostic distinction between mesothelioma and metastatic carcinoma in pleura. Histopathology 2001;38:528-534.PubMedCrossRefGoogle Scholar
  29. 29.
    Hajdu SI, Hajdu EO. Cytopathology of sarcomas and other nonepithelial malignant tumors. Philadelphia, WB Saunders, 1976.Google Scholar
  30. 30.
    Halliday BE, Slagel DD, Elsheikh TE, Siverman JF. Diagnostic utility of MIC-2 immunocytochemical staining in the differential diagnosis of small blue cell tumors. Diagn Cytopathol 1998;19:410-416.PubMedCrossRefGoogle Scholar
  31. 31.
    Hoekman K, Tognon G, Risse EK et al. Well-differentiated papillary mesothelioma of the peritoneum: a separate entity. Eur J Cancer 1996;32A:255-258.CrossRefGoogle Scholar
  32. 32.
    Hudelist G, Singer CF,Kubista E, et al. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004;45:633-637.PubMedCrossRefGoogle Scholar
  33. 33.
    Hurlimann J. Desmin and neural marker expression in mesothelial cells and mesotheliomas. Hum Pathol 1994;25:753-757.PubMedCrossRefGoogle Scholar
  34. 34.
    Illei PB, Ladanyi M, Rusch VW, Zakowski MF: The use of CDK-N2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer Cytopathol 2003;99:51-56.Google Scholar
  35. 35.
    Izban KF, Pooley RJ, Selvaggi SM, Alkan S. Cytologic diagnosis of peripheral T-cell lymphoma manifesting as ascites. A case report. Acta Cytol 2001;45:385-392.PubMedCrossRefGoogle Scholar
  36. 36.
    Joseph MG, Banerjee D, Harris P, et al. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry. Mod Pathol 1995;8:686-693.PubMedGoogle Scholar
  37. 37.
    King J, Thatcher N, Pickering C, Hasleton P. Sensitivity and specificity of immunohistochemical antibodies used to distinguish between benign and malignant pleural disease: a systematic review of published reports. Histopathology 2006;49:561-568PubMedCrossRefGoogle Scholar
  38. 38.
    Kwee WS, Veldhuizen RW, Alons CA, et al. Quantitative and qualitative differences between benign and malignant mesothelial cells in pleural fluid. Acta Cytol 1982;26:401-406.PubMedGoogle Scholar
  39. 39.
    Maeder M, Spieler P, Krapf R, Diethelm M. Cytologically malignant lymphoid pericardial effusion with benign clinical outcome. Report of two cases. Swiss Med Wkly 2005;135:377-381.PubMedGoogle Scholar
  40. 40.
    Mangano WE, Cagle PT, Churg A, et al. The diagnosis of desmoplastic malignant mesothelioma and its distinction from fibrous pleurisy: a histologic and immunohistological analysis of 31 cases including p53 immunostaining. Am J Clin Pathol 1998;110:191-199.PubMedGoogle Scholar
  41. 41.
    Marchevsky AM, Wick MR. Evidence-based guidelines for the utilization of immunostains in diagnostic pathology: pulmonary adenocarcinoma versus mesothelioma. Appl Immunohistochem Mol Morphol 2007;15:140-144.PubMedCrossRefGoogle Scholar
  42. 42.
    Mayall FG, Gibbs AR. The histology and immunohistochemistry of small cell mesothelioma. Histopathology 1992;20:47-51.PubMedCrossRefGoogle Scholar
  43. 43.
    Mayall FG, Goddard H, Gibbs AR. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J Pathol 1992;168:377-381.PubMedCrossRefGoogle Scholar
  44. 44.
    Mihaescu A, Gebhard S, Chaubert P, et al. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping. Diagn Cytopathol 2002;27:90-95.PubMedCrossRefGoogle Scholar
  45. 45.
    Motherby H, Kube M, Friedrichs N, et al. Immunocytochemistry and DNA-image cytometry in diagnostic effusion cytology I. Prevalence of markers in tumour cell positive and negative smears. Anal Cell Pathol 1999;19:7-20.PubMedGoogle Scholar
  46. 46.
    Motherby H, Pomjanski N, Kube M, et al. Diagnostic DNA-flowvs. image-cytometry in effusion cytology. Anal Cell Pathol 2002;24:5-15.PubMedGoogle Scholar
  47. 47.
    Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 1996;88:645-656.PubMedGoogle Scholar
  48. 48.
    Naylor B. Pleural, Peritoneal and Pericardial fluids. In: Bibbo M. (ed). Comprehensive Cytopathology. W.B. Saunders Company, Philadelphia, 1991,pp.585-587.Google Scholar
  49. 49.
    Olson PR, Silverman JF, Powers CN. Pleural fluid cytology of Hodgkin’s disease: Cytomorphologic features and the value of immunohistochemical studies. Diagn Cytopathol 2000,22:21-24.PubMedCrossRefGoogle Scholar
  50. 50.
    Onofre FB, Onofre AS, Pomjanski N, et al. 9p21 deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM and AgNOR analysis. Cancer(Cancer Cytopathol) 2008;114:204-215.Google Scholar
  51. 51.
    Osterheld MC, Liette C, Anca M. Image Cytometry: An aid for cytological diagnosis of pleural effusions. Diagn Cytopathol 2005;32:173-176.PubMedCrossRefGoogle Scholar
  52. 52.
    Parwani AV, Chan Ty, Ali SZ. Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis. Cancer 2004;102:87-91.PubMedCrossRefGoogle Scholar
  53. 53.
    Pokieser L. et al. Klinische Zytologie der Lunge und Pleura. Springer-Verlag Wien, 2001.CrossRefGoogle Scholar
  54. 54.
    Roberts F, McCall AE, Burnett RA. Malignant mesothelioma: a comparison of biopsy and postmortem material by light microscopy and immunohistochemistry. J Clin Pathol 2001;54:766-770.PubMedCrossRefGoogle Scholar
  55. 55.
    Rojo Sebastian A, Fernandez Morejon FJ, Bretcha Boix P, et al. Controversial origin of pseudomyxoma peritonei. Clin Transl Oncol 2006;8:767-769.PubMedCrossRefGoogle Scholar
  56. 56.
    Santos GC, Longatti-Filho A, de Carvalho LV, et al. Immunocytochemical study of malignant lymphoma in serous effusions. Acta Cytol 2000;44:539-542.PubMedCrossRefGoogle Scholar
  57. 57.
    Savic S, Franco N, Grilli B, Barascud Ade V, Herzog M, Bode B, Loosli H, Spieler P, et al. Fluorescence in situ hybridization in the definitive diagnosis of malignant mesothelioma in effusion cytology. Chest 2010;138:137-44.PubMedCrossRefGoogle Scholar
  58. 58.
    Sherman ME, Mark EJ. Effusion cytology in the diagnosis of malignant epithelioid and biphasic pleural mesothelioma. Arch Pathol Lab Med 1990;114:845-851.PubMedGoogle Scholar
  59. 59.
    Shield PW, Koivurinne K. The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Cytopathology 2008;19:218-223.PubMedCrossRefGoogle Scholar
  60. 60.
    Shin HJ, Shin DM, Tarco E, Sneige N. Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma. Cancer 2003;99:233-239.PubMedCrossRefGoogle Scholar
  61. 61.
    Spieler P, Gloor F. Identification of Types and primary sites of malignant Tumors by examination of exfoliated tumor cells in serous fluids. Comparison with the diagnostic accuracy on small histologic biopsies. Acta Cytol 1985;29:753-767.PubMedGoogle Scholar
  62. 62.
    Spieler P, Kradolfer D, Schmid U. Immunocytochemical characterization of lymphocytes in benign and malignant lymphocyte-rich serous effusions. Virchows Arch Pathol Anat 1986;409:211-221.CrossRefGoogle Scholar
  63. 63.
    Stewart CJ, Tsukamoto T, Cooke B, et al. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei. Pathology 2006;38:534-538.PubMedCrossRefGoogle Scholar
  64. 64.
    Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260-271.PubMedGoogle Scholar
  65. 65.
    Wakely PE Jr, Menezes G, Nuovo GJ. Primary effusion lymphoma: Cytopathologic diagnosis using in situ molecular genetic analysis for human herpesvirus 8. Mod Pathol 2002;15:944-950.PubMedCrossRefGoogle Scholar
  66. 66.
    Whitaker D. Cell aggregates in malignant mesothelioma. Acta Cytol 1977;21:236-239.PubMedGoogle Scholar

Further Reading (Sect. 3.3)

  1. 1.
    Barnetson RJ, Burnett RA, Downie I, et al. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum.Am J Clin Pathol 2006;125:67-76.PubMedGoogle Scholar
  2. 2.
    Batt RE, Smith RA, Buck Louis GM, et al. Müllerianosis. Histol Histopathol. 2007;22:1161-1166.PubMedGoogle Scholar
  3. 3.
    Covell JL, Carry JB, Feldman PS. Peritoneal washings in ovarian tumors. Potential sources of errors in cytologic diagnosis. Acta Cytol 1985;29:310-316.PubMedGoogle Scholar
  4. 4.
    Cusso X,Marti-Vincente A,Mones-Xiol J,Vilardell F. Laparoscopic cytology – an evaluation. Endoscopy 1988;20:102-103.PubMedCrossRefGoogle Scholar
  5. 5.
    DeMay RM. The Art and Science of Cytopathology, Exfoliative Cytology. Amer Soc of Clinical Pathologists. 1996; p.288.Google Scholar
  6. 6.
    Gu M, Shi W, Barakat RR, et al. Peritoneal washings in endometrial carcinoma. A study of 298 patients with histopathologic correlation. Acta Cytol 2000;44:783-789.PubMedCrossRefGoogle Scholar
  7. 7.
    Gupta PK, Albritton N, Erozan YS, Frost JK. Occurrence of cilia in exfoliated ovarian adenocarcinoma cells. Diagn Cytopathol 1985:1:228-231.PubMedCrossRefGoogle Scholar
  8. 8.
    Gurley AM, Hidvegi DF, Cajulis RS, Bacus S. Morphologic and morphometric features of low grade serous tumours of the ovary. Diagn Cytopathol 1994;11:220-225.PubMedCrossRefGoogle Scholar
  9. 9.
    Hudelist G, Singer CF,Kubista E, et al. Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004;45: 633-637.PubMedCrossRefGoogle Scholar
  10. 10.
    Ioakim-Liossi A, Karakitsos P, Aroni K, et al. P53 protein expression and DNA ploidy in common epithelial tumors of the ovary. Acta Cytol 1997;41:1714-1718.PubMedCrossRefGoogle Scholar
  11. 11.
    Korabiowska M, Brinck U, Skubis J, et al. Application of new ploidy-related parameters for the diagnosis of ovarian tumors. Anticancer Res 2004;24:4191-4194.PubMedGoogle Scholar
  12. 12.
    Luesley DM, Williams DR, Ward K, et al. Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease. Acta Cytol 1990;34:539-544.PubMedGoogle Scholar
  13. 13.
    Martin JK, Goellner JR. Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 1986;61:467-471.PubMedGoogle Scholar
  14. 14.
    Mulvany N. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids. Acta Cytol 1996;40:1231-1239.PubMedCrossRefGoogle Scholar
  15. 15.
    Nagai N, Oshita T, Fujii T, et al. Are DNA ploidy and epidermal growth factor receptor prognostic factors for untreated ovarian cancer? A prospective study. Am J Clin Oncol 2001;24:215-221.PubMedCrossRefGoogle Scholar
  16. 16.
    Osterberg L, Akeson M, Levan K, et al. Genetic alterations of serous borderline tumors of the ovary compared to stage I serous ovarian carcinomas. Cancer Genet Cytogenet 2006;167:103-108.PubMedCrossRefGoogle Scholar
  17. 17.
    Özkara SK, Turan G. Cystic fluid and fine needle aspiration cytopathology of cystic adult granulosa cell tumor of the ovary. A case report. Acta Cytol 2008;52:247-250.PubMedCrossRefGoogle Scholar
  18. 18.
    Parwani AV, Chan Ty, Ali SZ. Significance of psammoma bodies in serous cavity fluid: a cytopathologic analysis. Cancer 2004;102:87-91.PubMedCrossRefGoogle Scholar
  19. 19.
    Prat J, De Nictolis M. Serous borderline tumors of the ovary: A long-term follow-up study of 137 cases, including 18 with a micropapillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111-1128.PubMedCrossRefGoogle Scholar
  20. 20.
    Ravinsky E. Cytology of Peritoneal Washings in gynecologic patients. Diagnostic criteria and pitfalls. Acta Cytol 1986;30:8-16.PubMedGoogle Scholar
  21. 21.
    Sadeghi S, Ylagan LR. Pelvic washing cytology in serous borderline tumors of the ovary using ThinPrep: are there cytologic clues to detecting tumor cells? Diagn Cytopathol 2004;30:313-319.PubMedCrossRefGoogle Scholar
  22. 22.
    Selvaggi SM. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol 2003;28:335-341.PubMedCrossRefGoogle Scholar
  23. 23.
    Shield P. Peritoneal washing cytology. Cytopathology 2004;15:131-141.PubMedCrossRefGoogle Scholar
  24. 24.
    Sidawy MK, Chandra P, Oertel YC. Detached ciliary tufts in female peritoneal washings. A common finding. Acta cytol 1987;31:841-844.PubMedGoogle Scholar
  25. 25.
    Yun Gong, Xiaoping Sun, Michael CW, et al. Immunocytochemistry of serous effusion specimens: a comparison of ThinPrep® vs. cell block. Diagn Cytopathol 2003;28:1-5.PubMedCrossRefGoogle Scholar
  26. 26.
    Ziselman EM, Harkavy SE, Hogan M, et al. Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms. Acta Cytol 1984;28:105-110.PubMedGoogle Scholar
  27. 27.
    Zuna RE, Mitchell ML. Cytologic findings in peritoneal washings associated with benign gynecologic disease. Acta Cytol 1988;32: 139-147.PubMedGoogle Scholar
  28. 28.
    Zuna RE, Mitchell ML, Mulick KA, Weijchert WM. Cytohistologic correlation of peritoneal washing cytology in gynecologic disease. Acta Cytol 1989;33:327-336.PubMedGoogle Scholar

Further Reading (Sect. 3.4)

  1. 1.
    Amstutz HC, Campbell P, Kossovsky N, Clarke IC. Mechanism and clinical significance of wear debris-induced osteolysis. Clin Orthop Relat Res 1992;276:7-18.PubMedGoogle Scholar
  2. 2.
    Belzunegui J, Maiz O, Lopez L, et al. Hydatid disease of bone with adjacent joint involvement. A radiological follow-up of 12 years. Br J Rheumatol 1997 ;36 :133-135.PubMedCrossRefGoogle Scholar
  3. 3.
    Bjelle A, Crocker PR, Huskisson EC. Crystal arthroplasties in osteo-arthritis - clinical aspects and laboratory techniques for crystal identification. Scand J Rheumatol Suppl. 1982 ;43 :23-33.PubMedGoogle Scholar
  4. 4.
    Bjelle A, Norberg B, Sjögren G. The cytology of joint exudates in rheumatoid arthritis. Morphology and preparation techniques. Scand J Rheumatol 1982 ;11 :124-128.PubMedCrossRefGoogle Scholar
  5. 5.
    Broderick PA, Corvese N, Pierik MG, et al. Exfoliative cytology interpretation of synovial fluid in joint disease. J Bone Joint Surg Am 1976 ;58 :396-399.PubMedGoogle Scholar
  6. 6.
    Chhieng DC, Boguniewicz A, McKenna BJ. Pigmented villonodular synovitis. Report of a case with diagnostic synovial fluid cytologic features. Acta Cytol 1997 ;41 :1811-1814.PubMedCrossRefGoogle Scholar
  7. 7.
    Dougados M. Synovial fluid cell analysis. Baillieres Clin Rheumatol 1996 ;10 :519-534.PubMedCrossRefGoogle Scholar
  8. 8.
    Dzisiow F. Cytological picture of synovial fluid in rheumatoid arthritis. Pol Med J 1966 ;5 :997-1003PubMedGoogle Scholar
  9. 9.
    Freemont AJ, Denton J, Chuck A, et al. Diagnostic value of synovial fluid microscopy: a reassessment and rationalisation. Ann Rheum Dis 1991 ;50 :101-107.PubMedCrossRefGoogle Scholar
  10. 10.
    Gupta S, Mishra RS. Cytologic appearance of pigmented villonodular synovitis. A case report. Acta Cytol 2002 ;46 :728-730.PubMedCrossRefGoogle Scholar
  11. 11.
    Kellner G, Klein G. Guidelines for synovial cytology. Z Rheumatol 1976 ;35 :141-153.PubMedGoogle Scholar
  12. 12.
    Kortekangas P, Aro HT, Tuominen J, Toivanen A. Synovial fluid leukocytosis in bacterial arthritis vs. reactive arthritis and rheumatoid arthritis in the adult knee. Scand J Rheumatol 1992 ;21 :283-288.PubMedCrossRefGoogle Scholar
  13. 13.
    McCarty DJ. Crystal identification in human synovial fluids. Methods and interpretation. Rheum Dis Clin North Am 1988 ;14 :253-267.PubMedGoogle Scholar
  14. 14.
    McLaughlin RE, Davis JS. Gout and pseudogout established by polarized light microscopy of synovial fluid. Methods and two case reports. Va Med Mon (1918) 1970 ;97 :345-349.Google Scholar
  15. 15.
    Naib ZM. Cytology of synovial fluids. Acta Cytol 1973 ;17 :299-309.PubMedGoogle Scholar
  16. 16.
    Nordström D, Konttinen YT, Bergroth V, et al. Synovial fluid cells in Reiter’s syndrome. Ann Rheum Dis 1985 ;44 :852-856.PubMedCrossRefGoogle Scholar
  17. 17.
    Rege J, Shet T, Naik L. Fine needle aspiration of tophi for crystal identification in problematic cases of gout. A report of two cases. Acta Cytol 2000 ;44 :433-436.PubMedCrossRefGoogle Scholar
  18. 18.
    Sah SP, Rani S, Mahto R. Fine Needle aspiration of gouty tophi: a report of two cases. Acta Cytol 2002 ;46 :784-785.PubMedGoogle Scholar
  19. 19.
    Sapkas GS, Stathakopoulos DP, Babis GC, Tsarouchas JK. Hydatid disease of bones and joints. 8 cases followed for 4-16 years. Acta Orthop Scand 1998 ;69 :89-94.PubMedCrossRefGoogle Scholar
  20. 20.
    Selvi E, Manganelli S, Catenaccio M, et al. Diff Quik staining method for detection and identification of monosodium urate and calcium pyrophosphate crystals in synovial fluids. Ann Rheum Dis 2001 ;60 :194-198.PubMedCrossRefGoogle Scholar
  21. 21.
    Siddaraju N, Bundele MM. Caseous, necrotic material and epithelioid cell granulomas in synovial fluid from a patient with tuberculous infection: a case report. Acta Cytol 2007 ;51 :597-598.PubMedCrossRefGoogle Scholar
  22. 22.
    Siddaraju N, Aier M, Yaranal PJ, Basu D. Cytology of urate milk in gouty arthritis: a case report. Acta Cytol 2007 ;51 :586-588.PubMedCrossRefGoogle Scholar
  23. 23.
    Suprun H, Mansoor I. An aspiration cytodiagnostic test for gouty arthritis: a case report. Acta Cytol 1973 ;17 :198-199.PubMedGoogle Scholar
  24. 24.
    Villanueva TG, Schumacher HR Jr. Cytologic examination of synovial fluid. Diagn Cytopathol 1987 ;3 :141-147.PubMedCrossRefGoogle Scholar
  25. 25.
    Wahane RN, Pangarkar MA, Bobhate SK. Fine needle aspiration cytology of a hydatid cyst of the pelvis and hip joint. Acta Cytol 2008 ;52 :381-384.PubMedCrossRefGoogle Scholar
  26. 26.
    Zaharopoulos P, Wong JY. Identification of crystals in joint fluids. Acta Cytol 1980 ;24 :197-202.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Peter Spieler
    • 1
  • Matthias Rössle
    • 2
  1. 1.Institut für PathologieKantonsspital St. GallenSt. GallenSwitzerland
  2. 2.Institut für Klinische PathologieUniversitätsSpital ZürichZürichSwitzerland

Personalised recommendations